Works by Mak, Lung‐Yi
Results: 58
Infection-related hospitalizations in the first year after inflammatory bowel disease diagnosis.
- Published in:
- Journal of Digestive Diseases, 2016, v. 17, n. 9, p. 610, doi. 10.1111/1751-2980.12397
- By:
- Publication type:
- Article
Gallstone Ileus in an Older Nursing Home Resident.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Alleviation of Hepatic Steatosis: Dithizone-Related Gut Microbiome Restoration During Paneth Cell Dysfunction.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.813783
- By:
- Publication type:
- Article
Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, p. 27, doi. 10.1111/jvh.13914
- By:
- Publication type:
- Article
Cigarette Smoking Is Associated With Lower Chance of Hepatitis B Surface Antigen Seroclearance and Altered Host Immunity.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 12, p. 847, doi. 10.1111/jvh.14007
- By:
- Publication type:
- Article
Role of HBsAg levels in guiding hepatitis B virus prophylaxis in pregnancy: Insights from a multi‐ethnic cohort.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 1, p. 3, doi. 10.1111/jvh.13893
- By:
- Publication type:
- Article
Hepatitis delta virus: Disease assessment and stratification.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, p. 11, doi. 10.1111/jvh.13777
- By:
- Publication type:
- Article
A large real‐world cohort study examining the effects of long‐term entecavir on hepatocellular carcinoma and HBsAg seroclearance.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 4, p. 397, doi. 10.1111/jvh.13237
- By:
- Publication type:
- Article
Hepatitis B core‐related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 12, p. 1473, doi. 10.1111/jvh.13191
- By:
- Publication type:
- Article
Fibrosis evolution in chronic hepatitis B e antigen‐negative patients across a 10‐year interval.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 7, p. 818, doi. 10.1111/jvh.13095
- By:
- Publication type:
- Article
Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapy.
- Published in:
- Expert Review of Gastroenterology & Hepatology, 2023, v. 17, n. 5, p. 443, doi. 10.1080/17474124.2023.2196405
- By:
- Publication type:
- Article
Tumor suppressive role of mitochondrial sirtuin 4 in induction of G2/M cell cycle arrest and apoptosis in hepatitis B virus-related hepatocellular carcinoma.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00470-8
- By:
- Publication type:
- Article
Impact of liver graft steatosis on long-term post-transplant hepatic steatosis and fibrosis via magnetic resonance quantification.
- Published in:
- Frontiers in Medicine, 2025, p. 1, doi. 10.3389/fmed.2024.1502055
- By:
- Publication type:
- Article
Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes—A real‐world study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 574, doi. 10.1111/dom.16049
- By:
- Publication type:
- Article
Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 12, p. 1943, doi. 10.3390/v16121943
- By:
- Publication type:
- Article
Early Treatment Consideration in Patients with Hepatitis B 'e' Antigen-Positive Chronic Infection: Is It Time for a Paradigm Shift?
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 5, p. 900, doi. 10.3390/v14050900
- By:
- Publication type:
- Article
Novel Antivirals in Clinical Development for Chronic Hepatitis B Infection.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 6, p. 1169, doi. 10.3390/v13061169
- By:
- Publication type:
- Article
Plasma Fibronectin Levels Identified via Quantitative Proteomics Profiling Predicts Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Territorywide Prevalence Study on Blood-Borne and Enteric Viral Hepatitis in Hong Kong.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy.
- Published in:
- Virology Journal, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12985-023-02140-w
- By:
- Publication type:
- Article
Risk of acute liver injury following the nirmatrelvir/ritonavir use.
- Published in:
- Liver International, 2023, v. 43, n. 12, p. 2657, doi. 10.1111/liv.15673
- By:
- Publication type:
- Article
On‐treatment gamma‐glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 59, doi. 10.1111/liv.15085
- By:
- Publication type:
- Article
Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long‐term nucleoside analogue.
- Published in:
- Liver International, 2019, v. 39, n. 7, p. 1217, doi. 10.1111/liv.14104
- By:
- Publication type:
- Article
The role of interleukin-27 in predicting spontaneous HBeAg seroconversion in chronic hepatitis B infection.
- Published in:
- Liver International, 2017, v. 37, n. 9, p. 1287, doi. 10.1111/liv.13372
- By:
- Publication type:
- Article
Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.
- Published in:
- Clinical & Translational Gastroenterology, 2018, v. 9, n. 6, p. 1, doi. 10.1038/s41424-018-0020-9
- By:
- Publication type:
- Article
Investigational RNA Interference Agents for Hepatitis B: RNA Interference Agents in Hepatitis B: R. W.-H. Hui et al.
- Published in:
- BioDrugs, 2025, v. 39, n. 1, p. 21, doi. 10.1007/s40259-024-00694-x
- By:
- Publication type:
- Article
Attitudes and perceptions of influenza vaccination among Hong Kong doctors and medical students before the 2009 pandemic.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Attitudes and perceptions of influenza vaccination among Hong Kong doctors and medical students before the 2009 pandemic.
- Published in:
- European Journal of Public Health, 2013, v. 23, n. 2, p. 257, doi. 10.1093/eurpub/cks014
- By:
- Publication type:
- Article
Development and validation of a therapy‐independent hepatocellular carcinoma survival prediction score.
- Published in:
- Liver Cancer International, 2022, v. 3, n. 2, p. 82, doi. 10.1002/lci2.45
- By:
- Publication type:
- Article
Small Extracellular Vesicle‐Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma.
- Published in:
- Advanced Science, 2023, v. 10, n. 26, p. 1, doi. 10.1002/advs.202302677
- By:
- Publication type:
- Article
Nidogen 1‐Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1.
- Published in:
- Advanced Science, 2020, v. 7, n. 21, p. 1, doi. 10.1002/advs.202002157
- By:
- Publication type:
- Article
Regression of liver fibrosis after HBsAg loss: A prospective matched case–control evaluation using transient elastography and serum enhanced liver fibrosis test.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 12, p. 2826, doi. 10.1111/jgh.16728
- By:
- Publication type:
- Article
Plasma interferon‐gamma‐inducible‐protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 1, p. 202, doi. 10.1111/jgh.16371
- By:
- Publication type:
- Article
Magnetic resonance imaging metrics and the predictability of adverse outcomes in on‐treatment Asian chronic hepatitis B.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 6, p. 1139, doi. 10.1111/jgh.15846
- By:
- Publication type:
- Article
Serum Mac‐2‐binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir‐treated chronic hepatitis B patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 10, p. 1817, doi. 10.1111/jgh.14637
- By:
- Publication type:
- Article
Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 1, p. 141, doi. 10.1111/jgh.13817
- By:
- Publication type:
- Article
Hepatitis B virus X protein promotes hepatocarcinogenesis via the activation of HMGA2/STC2 signaling to counteract oxidative stress-induced cell death.
- Published in:
- Carcinogenesis, 2022, v. 43, n. 7, p. 671, doi. 10.1093/carcin/bgac030
- By:
- Publication type:
- Article
A qualitative systematic review of anonymous/unspecified living kidney and liver donors' perspectives.
- Published in:
- PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0277792
- By:
- Publication type:
- Article
Anti-HBc: a significant host predictor of spontaneous HBsAg seroclearance in chronic hepatitis B patients - a retrospective longitudinal study.
- Published in:
- BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02983-1
- By:
- Publication type:
- Article
Chronic Viral Hepatitis in Elite Athletes: Approaches to Risk Assessment, Prevention and Management.
- Published in:
- Sports Medicine - Open, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40798-022-00517-9
- By:
- Publication type:
- Article
Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 2, p. e276, doi. 10.1210/clinem/dgae223
- By:
- Publication type:
- Article
Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver‐related mortality in patients with diabetes.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1398, doi. 10.1111/apt.18254
- By:
- Publication type:
- Article
Editorial: Decoding the enigma—Navigating complexity in MASLD management.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Editorial: HBsAg seroclearance after pegylated interferon treatment—The beginning of the end.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Editorial: Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation—Insights from a real‐world study.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Living in the non‐alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 570, doi. 10.1111/apt.17121
- By:
- Publication type:
- Article
Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID‐19: a self‐controlled case series study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 1, p. 121, doi. 10.1111/apt.16894
- By:
- Publication type:
- Article
Editorial: liver and kidney injury from remdesivir—an issue not as much as its purpose. Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial